John Marshall, MD - Re-Invigorating the Later-Line Treatment of Metastatic Colorectal Cancer: Practical Strategies to Optimize the Use of Tyrosine Kinase Inhibitors

0:00-22:43

Please visit answersincme.com/KTK860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gastrointestinal cancers discusses strategies for treatment of patients with colorectal cancer using tyrosine kinase inhibitors. Upon completion of this activity, participants should be better able to: Identify patients with metastatic colorectal cancer (mCRC) who are suitable for tyrosine kinase inhibitor (TKI) treatment; Outline practical, patient-centered strategies to maximize quality of life in patients receiving later-line TKI treatment for mCRC; and Review approaches to manage adverse events associated with later-line TKI treatment for mCRC.

Publisher

CME in Minutes: Education in Gastroenterology

Link

answersincme.com/KTK860

Published

July 18, 2025

Duration

23 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Answers in CME

CI

CME in Minutes: Education in Gastroenterology

@cmeinminuteseducationingastr

#metastaticcolorectalcancer #practicalstrategies #tyrosinekinaseinhibitors #lifesciences #medicine

The Nile